MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
MYOMO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.25+0.05 (+4.17%)
Close on Oct 19, 2026
- Market cap
- $53.37M
- P/E (TTM)
- –
- Dividend yield
- –
MYOMO, INC. revenue by segment
By business segment
By product or service
| Revenue | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $9.83M | $12.07M | $9.21M | $7.52M | $3.75M | $4.76M | $5.03M | $4.24M | $3.45M | $4.04M | $3.97M | $3.68M | 100.0% | +161.9% |
| License [Member] | – | $0 | $0 | $0 | – | $0 | $50.00K | $1.71M | $0 | $0 | $0 | $0 | – | – |
By region
From the segment and revenue-disaggregation notes of Myomo's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.